Billionaire entrepreneur Elon Musk’s brain chip startup Neuralink said Tuesday it has received approval from an independent review board to begin recruiting for the first human trial of its brain implant for stroke patients.
People with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may be eligible for the study, he said, but he did not say how many participants would be included in the trial, which is expected to be completed. It will take about six years to happen.
The study will use a robot to surgically implant a brain-computer interface (BCI) implant in an area of the brain that controls the intention to move, Neuralink said, with the initial goal of allowing people to use a computer cursor or Enables keyboard control. Using your thoughts alone.
The company, which had previously hoped to gain approval to deploy its device. 10 patientswas negotiating with the US Food and Drug Administration (FDA) on a lower number of patients after the agency was lifted. Safety concernsAccording to current and former employees. It is not known how many patients the FDA ultimately approved.
Musk has big ambitions for Neuralink, which he says will facilitate faster surgical insertion of his chip devices to treat conditions like obesity, autism, depression and schizophrenia.
Even if the BCI device proves safe for human use, it will likely take more than a decade for the startup to get approval for commercial use. Experts.